← back to search

Michał Tendera

Medical University of Silesia · PL
Area of research
Cardiology and Cardiovascular Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Cardiac Imaging and Diagnostics, Acute Myocardial Infarction Research, Coronary Interventions and Diagnostics, and Heart Failure Treatment and Management.
h-index
105
citations
185,631
works
628
NIH funding
primary concept
Medicine
email

Recent publications

Hypertrophic cardiomyopathy and atrial fibrillation: the Cardiomyopathy/Myocarditis Registry of the EURObservational Research Programme of the European Society of Cardiology
Open Heart 2025cited by 9position: middledoi
Smoking trajectories and residual cardiovascular risk in patients with stable coronary artery disease: an international cohort study
European Journal of Preventive Cardiology 2025cited by 3position: middledoi
Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry
European Heart Journal 2024cited by 42position: middledoi
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI
Journal of the American College of Cardiology 2024cited by 29position: middledoi
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry
European Heart Journal 2024cited by 29position: middledoi
Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial
European Heart Journal 2024cited by 23position: middledoi
Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry
European Heart Journal 2024cited by 6position: middledoi
Sex differences in management of LDL-cholesterol in patients with chronic coronary syndrome
European Heart Journal 2024cited by 2position: middledoi
Trajectories in smoking habits and outcomes in patients with stable coronary artery disease
European Heart Journal 2024cited by 0position: middledoi
New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry
European Heart Journal 2023cited by 16position: middledoi
Association between coffee or tea consumption and cardiovascular outcomes in patients with stable coronary artery disease: Analysis from the CLARIFY registry
Archives of cardiovascular diseases 2023cited by 7position: middledoi
Optimal or standard control of systolic and diastolic blood pressure across risk factor categories in patients with chronic coronary syndromes
European Journal of Preventive Cardiology 2023cited by 3position: middledoi
New-onset atrial fibrillation in chronic coronary syndrome outpatients. Insights from the international CLARIFY registry
European Heart Journal 2023cited by 2position: middledoi
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
New England Journal of Medicine 2022cited by 693position: middledoi
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry
European Heart Journal - Quality of Care and Clinical Outcomes 2022cited by 44position: middledoi
International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina: The Multinational CLARIFY Study
Circulation 2021cited by 60position: middledoi
Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities
European Journal of Preventive Cardiology 2021cited by 38position: middledoi
Chronic coronary syndrome patients with polyarterial disease are a high risk but heterogenous subset of patients. Insights from the CLARIFY registry
Archives of Cardiovascular Diseases Supplements 2021cited by 0position: middledoi
New-onset atrial fibrillation in chronic coronary syndrome outpatients: Insights from the international CLARIFY registry
Archives of Cardiovascular Diseases Supplements 2021cited by 0position: middledoi
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction
American Heart Journal 2020cited by 85position: middledoi
Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial
The Lancet 2020cited by 73position: middledoi
Impact of smoking on cardiovascular outcomes in patients with stable coronary artery disease
European Journal of Preventive Cardiology 2020cited by 43position: middledoi
ESC EORP Cardiomyopathy Registry: Real-Life Practice of Genetic Counselling and Testing in Adult Cardiomyopathy Patients
ESC Heart Failure 2020cited by 36position: middledoi
Differences Between Familial and Sporadic Dilated Cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis Registry
ESC Heart Failure 2020cited by 34position: middledoi
Atrial Fibrillation, Anticoagulation Management and Risk of Stroke in the Cardiomyopathy/Myocarditis Registry of the EURObservational Research Programme of the European Society of Cardiology
ESC Heart Failure 2020cited by 27position: lastdoi
Simple risk models to predict cardiovascular death in patients with stable coronary artery disease
European Heart Journal - Quality of Care and Clinical Outcomes 2020cited by 8position: middledoi
Prognosis in patients with prior myocardial infarction and PEGASUS-TIMI 54 criteria in the CLARIFY registry
European Heart Journal 2020cited by 0position: middledoi
Cardiovascular risk of chronic coronary syndrome patients according to vascular phenotype, diabetes, and smoking
European Journal of Preventive Cardiology 2020cited by 0position: middledoi
Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry
European Heart Journal 2019cited by 98position: middledoi
Chronic Kidney Disease Has a Graded Association with Death and Cardiovascular Outcomes in Stable Coronary Artery Disease: An Analysis of 21,911 Patients from the CLARIFY Registry
Journal of Clinical Medicine 2019cited by 24position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Roberto Ferrari · German Centre for Cardiovascular Research36 papers (2012–2025)Philippe Gabríel Steg · Mount Sinai Hospital35 papers (2012–2025)Kim Fox · Imperial College London31 papers (2012–2024)Ian Ford · University of Glasgow31 papers (2012–2025)Jean‐Claude Tardif · United States Nuclear Regulatory Commission19 papers (2012–2025)Nicola Greenlaw · University of Glasgow13 papers (2012–2020)Grégory Ducrocq · Département de mathématiques et applications13 papers (2018–2025)Nicolas Danchin · Hospital Universitario Virgen de la Arrixaca12 papers (2014–2025)Jean‐Claude Tardif · University of Glasgow9 papers (2012–2024) · 9 papers (2018–2021) · 9 papers (2018–2023)Emmanuelle Vidal‐Petiot · Université Claude Bernard Lyon 18 papers (2016–2025)Luigi Tavazzi · National Health and Medical Research Council7 papers (2013–2025)Jules Mesnier · Université Laval5 papers (2021–2025)Robin Young · University of Cambridge5 papers (2018–2021)Aldo P. Maggioni · Policlinico Umberto I4 papers (2020–2025) · 4 papers (2012–2014)Ian Ford · Amgen (United States)4 papers (2012–2024)Cécile Laroche · Hôpital Mère-Enfant4 papers (2020–2025) · 4 papers (2018–2023)